SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AlienTech who wrote (10995)7/9/1998 5:44:00 PM
From: Colby  Read Replies (2) of 23519
 
If tomorrow acts lousy, I think it could be a good buying opportunity.
IMO, the next news we here from the company will be one of two things, 1)Domestic partner 2) buyout. Either one of these events will drive the price up.

I gotta go and I'll be gone the next two trading days. Boo!Hoo!. I'm gonna miss all the fun. The last time I missed trading days, the stock jumped up, so who knows?

The conference call did not add too much light to the sit.
A brief summary
1. will save 12-15MM/quarter in SG&A
2. Still going ahead with IReland
3. "Hopefull" VVUS will be proffitable in Q3
4. VVUS only participates in the bonus with the Alza agreement
5. Allibra 26% more effective than Muse.
6. In talks as we speak with major US marketing partner. We'll see.
7. Cost per unit were about $5.35. "Hopefull" they can reduce costs by over 25%
8. The company is selling internationally in the black.
9.A total of 25 country approvals expected by year end.
10. Won't be skimpy on R&D
11. I got the feeling they were nervous about PFE's direct to consumer launch.

We shall see. Have a great weekend.
Colby
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext